1. Academic Validation
  2. Construction of 4"-isovalerylspiramycin-I-producing strain by in-frame partial deletion of 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1, the bitespiramycin producer

Construction of 4"-isovalerylspiramycin-I-producing strain by in-frame partial deletion of 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1, the bitespiramycin producer

  • Curr Microbiol. 2011 Jan;62(1):16-20. doi: 10.1007/s00284-010-9664-8.
Chunyan Ma 1 Hongxia Zhou Jingyan Li Jianlu Dai Weiqing He Hongyuan Wang Linzhuan Wu Yiguang Wang
Affiliations

Affiliation

  • 1 Key Lab of Biotechnology of Antibiotics, Ministry of Health, Institute of Medicinal Biotechnology, CAMS & PUMC, 100050, Beijing, China.
Abstract

Bitespiramycin (BT), a multi-component Antibiotic consisted mainly of 4"-isovalerylspiramycin I, II and III, is produced by Streptomyces spiramyceticus WSJ-1, a recombinant spiramycin-production strain that harbored the 4"-O-acyltransferase gene (ist) from Streptomyces mycarofaciens 1748, which could isovalerylate the 4"-OH of spiramycin. To eliminate the production of components 4"-isovalerylspiramycin II and III, therefore reducing the component complexity of BT, inactivation of the sspA gene, which encodes the 3-O-acyltransferase responsible for the acylation of spiramycin I to spiramycin II and III, was performed in Streptomyces spiramyceticus WSJ-1, by in-frame partial deletion. The resulting strain, Streptomyces spiramyceticus WSJ-2, is a 4"-isovalerylspiramycin-I-producing strain as expected.

Figures
Products